| Product Code: ETC12942805 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya mRNA Vaccines and Therapeutics Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Kenya mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.7 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.9 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Kenya mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in mRNA vaccine and therapeutics research |
4.2.2 Increasing government initiatives and funding for healthcare infrastructure in Kenya |
4.2.3 Rising prevalence of infectious diseases and chronic conditions in Kenya |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA vaccine and therapeutics development and production |
4.3.2 Lack of awareness and acceptance of mRNA vaccines and therapeutics among the population in Kenya |
5 Kenya mRNA Vaccines and Therapeutics Market Trends |
6 Kenya mRNA Vaccines and Therapeutics Market, By Types |
6.1 Kenya mRNA Vaccines and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031F |
6.1.4 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Influenza Vaccine, 2021 - 2031F |
6.1.5 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Rabies Vaccine, 2021 - 2031F |
6.1.6 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Zika Virus Vaccine, 2021 - 2031F |
6.1.7 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By CMV Vaccine, 2021 - 2031F |
6.2 Kenya mRNA Vaccines and Therapeutics Market, By Therapeutic Type |
6.2.1 Overview and Analysis |
6.2.2 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.3 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031F |
6.2.4 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.2.5 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031F |
6.2.6 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By mRNA-Based Drug Delivery, 2021 - 2031F |
6.3 Kenya mRNA Vaccines and Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.5 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3.6 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.4 Kenya mRNA Vaccines and Therapeutics Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intramuscular Injection, 2021 - 2031F |
6.4.3 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Subcutaneous Injection, 2021 - 2031F |
6.4.4 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intradermal Injection, 2021 - 2031F |
6.4.5 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intravenous Infusion, 2021 - 2031F |
6.4.6 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oral Delivery, 2021 - 2031F |
6.5 Kenya mRNA Vaccines and Therapeutics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.4 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.5.6 Kenya mRNA Vaccines and Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 Kenya mRNA Vaccines and Therapeutics Market Import-Export Trade Statistics |
7.1 Kenya mRNA Vaccines and Therapeutics Market Export to Major Countries |
7.2 Kenya mRNA Vaccines and Therapeutics Market Imports from Major Countries |
8 Kenya mRNA Vaccines and Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for mRNA vaccines and therapeutics in Kenya |
8.2 Percentage increase in healthcare expenditure allocated towards mRNA vaccines and therapeutics |
8.3 Number of partnerships and collaborations between local and international pharmaceutical companies for mRNA vaccine and therapeutics development in Kenya |
9 Kenya mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
9.1 Kenya mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Kenya mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
9.3 Kenya mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Kenya mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.5 Kenya mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Kenya mRNA Vaccines and Therapeutics Market - Competitive Landscape |
10.1 Kenya mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Kenya mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here